All treatments
Treatment
Placebo is identical to IMP but with no active substance., Batoclimab clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG)
This study is looking into a new treatment called Batoclimab for adults with a muscle weakness condition called generalized Myasthenia Gravis (gMG). It wants to see if the treatment helps improve daily activities and if it's safe to use.
For: Generalized Myasthenia Gravis (gMG)Romania · Germany · Italy - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
This study is testing a new medicine, Batoclimab, for people with an eye condition called Thyroid Eye Disease (TED). We want to see if this medicine can help reduce bulging eyes and improve other eye symptoms compared to a dummy medicine.
For: Thyroid Eye DiseaseSlovakia · Spain · Hungary - Ongoing, recruitingTherapeutic confirmatory (Phase III)
IMVT-1401-3201: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
This study is testing a new medicine, batoclimab, for active Thyroid Eye Disease (TED). We want to see if it can help reduce bulging eyes (proptosis) and improve other symptoms, compared to a dummy medicine, in adults with TED.
For: Thyroid Eye Disease (TED)Italy · Poland · Germany